Clinical Trial Update: Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a plant-derived quadrivalent virus-like particle (VLP) vaccine in elderly populations has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Diseases
• Respiratory Tract Infections
• Rna Virus Infections
• Virus Diseases

Drugs mentioned

• plant-derived quadrivalent virus-like particle (VLP) vaccine

Snippet

Sponsor: Medicago | Conditions: Virus Diseases, RNA Virus Infections | Phase 3 | Status: COMPLETED | Results posted: 2023-06-23